-
Y-27632: A Translational Probe for ROCK Biology
2026-08-19
Y-27632 is more than a routine cytoskeletal reagent: it can help translational researchers test how ROCK-dependent force generation intersects with STIM1-driven calcium signaling and prostate cancer dissemination. This article connects the compound’s mechanism, practical assay design, selectivity profile, and limitations to the TSPAN18–STIM1 bone-metastasis study by Zhou et al.
-
Zolmitriptan: 5-HT1B Agonist for Migraine Research
2026-08-19
Zolmitriptan is a selective serotonin-receptor research compound centered on 5-HT1B and 5-HT1D pharmacology. Its receptor activity supports mechanistic studies of migraine, cranial vasoconstriction, trigeminal signaling, and cluster headache biology.
-
Continuous Rotigotine Delivery in PD and RLS
2026-08-18
The reference review explains how rotigotine’s lipid solubility, receptor pharmacology, and rapid metabolism supported development of a transdermal system for sustained dopaminergic stimulation. Its central practical implication is that continuous exposure may address limitations associated with short-acting, pulsatile dopamine replacement in Parkinson’s disease and restless legs syndrome, although clinical translation requires careful separation of formulation, disease, and assay variables.
-
Flubendazole and the Strategy of Autophagy Modulation
2026-08-18
A translational framework for using Flubendazole to interrogate autophagy biology, separate cytostatic effects from cell death, and build more decision-ready cancer research workflows.
-
Biotin-azide for Reliable Cell Assays
2026-08-17
Learn how Biotin-azide (SKU A8013) can strengthen proliferation, cytotoxicity, and biomolecule-labeling workflows through terminal-alkyne-selective CuAAC chemistry. This scenario-driven guide covers assay compatibility, protocol optimization, data interpretation, and practical product selection.
-
Sunitinib Workflow for RTK and Glioma Research
2026-08-17
Build a reproducible Sunitinib workflow that connects RTK blockade with ATRX-stratified glioma assays, apoptosis, and cell-cycle analysis. Practical dosing, combination-testing, and troubleshooting guidance helps distinguish target engagement from nonspecific cytotoxicity.
-
(-)-JQ1 as a Causal Control in AML Assays
2026-08-16
(-)-JQ1 is an inactive JQ1 stereoisomer that strengthens causal interpretation in BET and AML experiments. This article connects stereochemical control with N-MYC/eIF4G1 biology, assay design, and reproducible epigenetics research.
-
Neuromedin S (rat): GPCR Assay Workflow
2026-08-15
Neuromedin S (rat), SKU B5466, provides a chemically defined endogenous peptide agonist for controlled neuromedin U receptor signaling studies. This guide covers reconstitution, storage, assay setup, and quality control, while defining the limits of use when assay-specific paper evidence, potency values, or cross-species validation are unavailable.
-
Cy5-UTP for Fluorescent RNA Probe Workflows
2026-08-14
Cy5-UTP enables direct, far-red visualization of RNA generated by T7 in vitro transcription, making it useful for FISH, multicolor assays, and RNA delivery studies. This workflow guide connects probe synthesis to targeted mRNA research while emphasizing label-ratio control, imaging compatibility, and troubleshooting.
-
JC-1 Mitochondrial Membrane Potential Assay Kit
2026-08-14
The JC-1 Mitochondrial Membrane Potential Assay Kit provides a ratiometric view of ΔΨm changes, helping researchers distinguish mitochondrial depolarization from broader apoptosis-associated effects. This guide connects JC-1 interpretation with a hypoxia-activated molecular-glue study and offers a mechanism-focused experimental framework.
-
Anti-ROR1 Antibody (Zilovertamab) in Mechanistic Assays
2026-08-13
Anti-ROR1 Antibody (Zilovertamab) can serve as a pathway-focused probe for ROR1 biology, while the DON liver-injury study provides a rigorous model for causal assay design. This article connects receptor blockade, orthogonal validation, and responsible cross-domain interpretation.
-
Rocilinostat (ACY-1215) in Reliable Cell Assays
2026-08-13
This scenario-driven guide shows how Rocilinostat (ACY-1215), SKU A4083, can support better-controlled viability, proliferation, and cytotoxicity studies through selective HDAC6 inhibition and disciplined compound handling. It also distinguishes product-supported evidence from practical workflow recommendations and clarifies the limits of extending cancer findings into neurodevelopmental models.
-
2,2,2-Trichloroethanol in Protein Workflows
2026-08-12
2,2,2-Trichloroethanol is a versatile small molecule biochemical for rapid protein visualization and electrophoresis quality control. This guide connects practical gel-based workflows with dopamine transporter studies, showing how orthogonal protein measurements can strengthen molecular biology research without overstating what the reagent can prove.
-
Bromodomain Inhibitor (+)-JQ1: Applied Workflows
2026-08-12
Bromodomain Inhibitor, (+)-JQ1 enables controlled BET and BRD4 perturbation across cancer, inflammation, and reproductive biology models. Its greatest experimental value emerges when researchers pair target-directed treatment with separate measurements of growth arrest, cell death, and pathway-specific responses.
-
Graphene-Induced Apoptosis in Melanoma Cells
2026-08-11
The reference study investigates graphene film as a physical treatment for B16F10 melanoma cells and links growth suppression to intrinsic apoptosis, oxidative stress, hypoxia-related signaling changes, and G0/G1 cell-cycle arrest. Its combination of RNA sequencing, biochemical assays, pharmacological rescue, and cell-cycle analysis provides a useful framework for dissecting how graphene-based thermal or far-infrared exposure affects tumor cells.